CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions - Top-Institutions - MDSpire

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

  • By

  • Chu Xin Ng

  • Sakina Mustafa

  • Xin Yi Yap

  • Sau Har Lee

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Minnesota Medical School
    University of Minnesota Medical School

    Minneapolis, Minnesota

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    University of California, Los Angeles (UCLA)
    University of California, Los Angeles (UCLA)

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #4

    Multidisciplinary Oncology and Therapeutic Innovations department
    Multidisciplinary Oncology and Therapeutic Innovations department

    Unknown, Unknown

    Key Differentiators

    • Oncology

  • #5

    Sapienza University of Rome
    Sapienza University of Rome

    Rome, Italy

    Key Differentiators

    • Oncology

Original Source(s)

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

  • by Chu Xin Ng, Sakina Mustafa, Xin Yi Yap, Sau Har Lee

  • July 17, 2026

Related Content

Clinical outcomes of atrial tachyarrhythmia hospitalizations with and without prior thoracic irradiation

Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort

Access to molecular diagnostics for CNS tumors through international outsourcing: experience from Jordan